The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Coronary Stents Market Expected To Change From 2026 To 2030?
The coronary stents market has experienced substantial expansion in recent years. This market is projected to expand from $11.9 billion in 2025 to $12.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.3%. Historically, this growth has been driven by factors such as the increasing incidence of coronary artery disease, a rise in percutaneous coronary intervention procedures, innovations in stent coating technologies, the broadening of interventional cardiology services, and better clinical results from coronary stenting.
The coronary stents market is anticipated to experience substantial expansion over the coming years. Projections indicate it will reach $17.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.3%. This projected growth is driven by factors such as an aging demographic prone to increased cardiovascular risk, a surging demand for less invasive cardiac procedures, the wider integration of advanced stent technologies, an elevated emphasis on sustained vessel recovery and patient results, and improved availability of cardiac interventions in developing regions. Key trends anticipated during this period encompass the increased use of drug-eluting and dual therapy stents, a growing inclination towards minimally invasive coronary procedures, a heightened commitment to mitigating risks of restenosis and thrombosis, the expanding application of bioresorbable and biodegradable stents, and an escalating need for innovative stent materials and designs.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp
Which Key Drivers Are Affecting The Coronary Stents Market Development?
The increasing prevalence of cardiovascular diseases (CVDs) is anticipated to propel the growth of the coronary stent market going forward. These conditions, known as cardiovascular diseases, encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population and an increased occurrence of risk factors like obesity, diabetes, sedentary lifestyles, a poor diet, and stress. A coronary stent is essential for individuals with cardiovascular diseases to open narrowed or blocked coronary arteries, thereby improving blood flow to the heart and reducing the risk of heart attacks. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, representing approximately one in every three deaths. Therefore, the escalating prevalence of cardiovascular diseases (CVDs) is driving the expansion of the coronary stent market.
Which Segments Define The Coronary Stents Market Segment Structure?
The coronary stents market covered in this report is segmented –
1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies
3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer
4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents
5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Subsegments:
1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents
What Trends Are Transforming The Coronary Stents Market?
Major companies operating in the coronary stent market are developing innovative products, such as drug-eluting stents, with the goal of reducing the necessity for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents featuring a medication coating designed to prevent the re-narrowing of arteries by gradually releasing drugs over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent is distinguished by its enhanced design, a new delivery system, and unique size options, specifically engineered to handle challenging medical cases. It retains the specialized coating that helps reduce the risk of artery re-blockage, consistent with other XIENCE stents. This particular stent benefits from an exceptional safety record, supported by over 120 clinical trials involving more than 120,000 patients.
Who Are The Established Players Within The Coronary Stents Market?
Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys
Get The Full Coronary Stents Market Report:
https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report
Which Region Leads The Coronary Stents Market In Terms Of Market Share?
North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Coronary Stents Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp
Browse Through More Reports Similar to the Global Coronary Stents Market 2026, By The Business Research Company
Atherectomy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/atherectomy-devices-global-market-report
Coronary Angiography Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model